Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$591,035
+$145,481 QoQ
Shares Held
7,959
+36.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 12.564392511622064.ToString("F0")%
Shared 0.ToString("F0")%
None 87.43560748837794.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fiduciary Trust Co holds $34,084,499 across 28 Biotechnology names. BBIO ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,876 | $8,875,428 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,161 | $7,247,876 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,478 | $6,550,441 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
17,898 | $1,740,580 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
8,541 | $1,614,675 | |
| 6 | VYGR |
Voyager Therapeutics, Inc.
|
334,397 | $1,290,772 | |
| 7 | FULC |
Fulcrum Therapeutics, Inc.
|
136,555 | $1,047,376 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
7,959 | $591,035 |
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $591,035 | 7,959 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $445,554 | 5,825 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $303,069 | 5,835 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||